fezolinetant 45 MG Oral Tablet [Veozah]
- RxCUI
- 2637147
- RxNorm name
- fezolinetant 45 MG Oral Tablet [Veozah]
- Display name
- fezolinetant 45 MG Oral Tablet [Veozah]
- Full name
- fezolinetant 45 MG Oral Tablet [Veozah]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VEOZAH | FEZOLINETANT | Astellas Pharma US, Inc. | cae9f798-24f9-4580-a4fc-e6c710cbda3c | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 2637147 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cae9f798-24f9-4580-a4fc-e6c710cbda3c | fezolinetant 45 MG Oral Tablet [Veozah] | SBD | 8 | These highlights do not include all the information needed to use VEOZAH safely and effectively. See full prescribing information for VEOZAH. VEOZAH ® (fezolinetant) tablets, for oral use Initial U.S. Approval: 2023 | 20260226 |
| cae9f798-24f9-4580-a4fc-e6c710cbda3c | Veozah 45 MG Oral Tablet | SY | 8 | These highlights do not include all the information needed to use VEOZAH safely and effectively. See full prescribing information for VEOZAH. VEOZAH ® (fezolinetant) tablets, for oral use Initial U.S. Approval: 2023 | 20260226 |
| cae9f798-24f9-4580-a4fc-e6c710cbda3c | VEOZAH 45 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use VEOZAH safely and effectively. See full prescribing information for VEOZAH. VEOZAH ® (fezolinetant) tablets, for oral use Initial U.S. Approval: 2023 | 20260226 |